Vikas Kumar*, Fahad Al-Abbasi, Firoz Anwar and Jonathan A. Lal Pages 1 - 22 ( 22 )
Introduction: Cerebral infarction, the blockage of blood vessels in the brain, is generally an age-related illness. Factors such as unhealthy diets, stressful behaviours and decreased environmental consistency with physiological barriers also contribute to increased casualties. Long-term brain function reconstruction and successful drug therapy are needed. The most frequent malignant brain tumour, glioblastoma, has been linked to variations in mitochondrial ROS, chaperone-mediated autophagy, and the interaction between lncRNA (BC200) and miRNA. Glioblastoma stem cells express high levels of ATP/P2X7 receptors, promoting survival by activating M2 muscarinic receptors.
Areas Covered: This expert opinion provides an overview of the latest experimental drug therapies aimed at protecting against and restoring cerebral stroke.
Expert Opinion: Nanomedicine overcomes the challenges associated with traditional therapy and physiological obstacles in the treatment of cerebral infarction by improving stroke management, including diagnosis, imaging, and treatment, addressing a diverse range of associated factors.
Ischemia, cerebral infarction, antioxidant and anti-neuroinflammatory drugs, nanomedicine.